Global Antibody Technologies Market: Overview

Immune system of the human body is similar to a highly trained army. It fights off the invading pathogens and that too very effectively, usually. However, the issue is that sometimes it does make mistakes and harmful pathogens attack us. This can lead to autoimmune diseases, allergies or just misfires in the immune system’s attack of invading pathogens. The global antibody technologies market is expected to gather momentum from the growing prevalence of pathogen invasion.

Monoclonal antibody technology is a type of technology that makes use of monoclonal antibodies so as to bind monospecifically to specific proteins and cells. This method of treatment triggers the immune system of patients to launch an attack on the foreign cells. These foreign cells that invade the body causes the disease, which is the why the global antibody technologies market is likely to grow. Monoclonal antibodies are made through utilization of hybridoma technology. In hybridoma technology, the antibodies are derived through fusion of human myeloma and human spleen cells. These features of the antibodies that influence their efficiency comprise affinity of the antibody for the target antigen or cells, the overall structure, and   antigen specificity. The efficiency of the antibody is expected to drive the global antibody technologies market over the period of projection, 2017 to 2025.

The report on the global antibody technologies market takes a closer look at the major changes that have taken place medical industry and the human immune system. The developments are expected to shape the contours of the global antibody technologies market in the years to come. The insights that have been provided in the report are likely to assist the investors and industry players to make an accurate assessment of the completive ecosystem and formulate strategies accordingly.

Global Antibody Technologies Market: Trends and Opportunities

Rising Geriatric Population with Weakening Immune System Boost Market Growth

Antibodies are the proteins that are produced by plasma cells of the human body and are utilized by the immune system of the body to figure out and resist foreign bodies invading the body of the host. Plasma cells are a certain type of white blood cells (WBC). Antibodies are also called immunoglobulin (Ig) and come in the shape of Y with a certain binding site for a specific antigen. An antigen is the foreign body that triggers an adaptive immune response.

Strength of the body’s immune system is directly proportional to one’s age. With the progression of one’s age, the number of people attacked by diseases caused by weak immunity is observed to rise. As such, the global antibody technologies market is likely to be driven by expanding pool of geriatric population with deteriorating immune systems. Increased research and development activities are conducted for the development of novel solutions to fight off antigens and prevent diseases. This factor is also likely to offer copious growth opportunities for the expansion of the global antibody technologies market.

On the other hand, shortage of funds in many of the poor and developing countries coupled with poor infrastructure are likely to restrict optimum utilization of the huge scope that exists for the global antibody technologies market. In addition, stringent government regulations are also likely to hamper growth of the market in the coming years.

Global Antibody Technologies Market: Regional Outlook

Key regions in the global antibody technologies market comprise North America, Europe, the Middle East and Africa (MEA), Latin America, and Asia Pacific.

Of these, Asia Pacific is likely to hold immense scope for the global antibody technologies market over the period of projection. North America is likely to account for a sizeable chunk of the global antibody technologies market due to the presence of advanced healthcare infrastructure and favorable reimbursement policies. In addition, increased funding and research and development activities are likely to add to the growth of the North America antibody technologies market in the years to come.

Global Antibody Technologies Market: Companies Mentioned in Report

Some of the prominent market players mentioned in the report are Shanghai RAAS Blood Products Co. Ltd, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd, Beijing Tiantan Biological Products Co. Ltd., Guizhou Taibang Biological Products Co. Ltd., China Biologic Products, Inc., and Beijing Tiantan Biological Products Co. Ltd.

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Antibody Technologies Market

Pre Book